In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy and …. Read More
More and more parents are filing lawsuits against GlaxoSmithKline LLC (“GSK”), maker of anti-nausea drug Zofran (ondansetron), after their children exposed to the drug were born with birth defects. The drug, approved by the FDA to only treat nausea and vomiting in cancer patients undergoing chemotherapy and patients who had major surgeries, has been marketed …. Read More
In February 2016, an Alabama couple spoke out openly about the hardships anti-nausea drug Zofran (ondansetron) has caused their family. During her pregnancy, Clara Rickman took a generic version of Zofran, ondansetron, which she claims led to her child being born with multiple congenital heart defects. The Rickmans say their son has undergone three surgeries …. Read More
Ashley Wright is one of dozens of women who have filed lawsuits against GlaxoSmithKline (“GSK”), maker of anti-nausea drug Zofran (ondansetron), and ten years later is finally speaking out about her experience after taking the drug. Zofran (ondansetron) was approved by the FDA to combat nausea and vomiting in cancer patients undergoing chemotherapy, but has been …. Read More
In the latest development of the Zofran (ondansetron) multi-district litigation, GlaxoSmithKline’s request for dismissal of all claims were denied by Judge F. Dennis Saylor IV, the Massachusetts district judge presiding over the litigation. About 200 cases with similar claims were consolidated into the multidistrict litigation, or “MDL,” for the purpose of streamlining pre-trial proceedings and …. Read More
